Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 32)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
20-Nov-09New Constructs, LLCN/ADNDN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
20-Nov-09Stock Traders DailyThomas H. Kee Jr.S&P Valuation Analysis13$50  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: DENDREON CORP -- DNDN1$4  View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of DENDREON CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS3$4  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DENDREON CORP5$25  View Abstract
14-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Dendreon Corporation42$65  View Abstract
12-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhDDNDN: Reports 3Q09 Results4$104 Stars  View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
12-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhDDNDN: Reports 3Q09 Results4$104 Stars  View Abstract
12-Nov-09Brean Murray & Co., Inc.Jonathan M. Aschoff PhD, Ryan Worst CFA, Andrey Glukhov CFA, Daniel FidellMorning Insight (CAST, KONG, CHDN, DNDN, KERX, ATO)9$254 Stars  View Abstract
11-Nov-09Thomson StreetEventsN/ADNDN - Event Transcript of Dendreon conference call, Nov. 11, 2009 / 4:30pm ET16$75  View Abstract

Independent Reports (Showing 1 to 10 of 29)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
20-Nov-09New Constructs, LLCN/ADNDN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
20-Nov-09Stock Traders DailyThomas H. Kee Jr.S&P Valuation Analysis13$50View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: DENDREON CORP -- DNDN1$4View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of DENDREON CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS3$4View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DENDREON CORP5$25View Abstract
14-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Dendreon Corporation42$65View Abstract
10-Nov-09EconomicInvestorN/A"The Economy Matters" Report for DNDN: the economy's impact on DNDN's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.